Immune-Mediated Necrotizing Myopathy Treatment Market – Addressing Rare Autoimmune Muscle Disorders
The Immune-Mediated Necrotizing Myopathy Treatment Market focuses on therapies and supportive care used to manage immune-mediated necrotizing myopathy (IMNM), a rare autoimmune muscle disease characterized by muscle weakness and muscle fiber damage. Treatment may involve immunosuppressive medicines, intravenous immunoglobulin, corticosteroids, and other specialist-directed therapies.
Current...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek